Misplaced Pages

#973026

44-651: In 1986, ACTRA transferred their awards to the Academy of Canadian Cinema & Television . The Academy called their television awards the Gemini Awards , or Prix Gémeaux in French. After their first Gemini awards ceremony for English-language television, the academy decided to have an awards ceremony for French-language television in 1987. In 2003 the Academy added categories for digital media. The first webcast for

88-509: A COVID‑19 vaccine candidate to boost its immunogenicity and efficacy to reduce or prevent COVID‑19 infection in vaccinated individuals. Adjuvants used in COVID‑;19 vaccine formulation may be particularly effective for technologies using the inactivated COVID‑19 virus and recombinant protein-based or vector-based vaccines. Aluminum salts, known as " alum ", were the first adjuvant used for licensed vaccines and are

132-621: A change in rules dictated that if there is only one show nominated in a category, that show can instead be entered into the category that is closest to its runtime. This rule allowed District 31 to apply for entry in the Best Seasonal Drama Series. Before 2015, production companies and producers would submit shows and individuals to be considered for a nomination. The Academy then created a nomination jury of five or six people who were selected because they had expertise and experience in that category. After viewing all entries,

176-464: A decade to develop. In contrast, mRNA is a molecule that can be made quickly, and research on mRNA to fight diseases was begun decades before the COVID‑19 pandemic by scientists such as Drew Weissman and Katalin Karikó , who tested on mice. Moderna began human testing of an mRNA vaccine in 2015. Viral vector vaccines were also developed for the COVID‑19 pandemic after the technology

220-850: A robust T-cell response and their genes are more conserved and recombine less frequently (compared to Spike). Future generations of COVID‑19 vaccines that may target more conserved genomic regions will also act as insurance against the manifestation of catastrophic scenarios concerning the future evolutionary path of SARS-CoV-2, or any similar coronavirus epidemic/pandemic. Platforms developed in 2020 involved nucleic acid technologies ( nucleoside-modified messenger RNA and DNA ), non-replicating viral vectors , peptides , recombinant proteins , live attenuated viruses , and inactivated viruses . Many vaccine technologies being developed for COVID‑19 are not like influenza vaccines but rather use "next-generation" strategies for precise targeting of COVID‑19 infection mechanisms. Several of

264-474: A second intranasal vaccine as a booster, trade name Pneucolin . Aivita Biomedical is developing an experimental autologous dendritic cell COVID‑19 vaccine kit where the vaccine is prepared and incubated at the point-of-care using cells from the intended recipient. The vaccine is undergoing small phase I and phase II clinical studies. A universal coronavirus vaccine would be effective against all coronaviruses and possibly other viruses. The concept

308-455: A special committee who suggests nominations but they have also sent calls for nominations from Academy members. A proposed nominee is then presented to the Quebec board of the Academy for approval. The special awards include "le Gémeau spécial des artisans" created in 2019 and "le prix spécial de la relève" is awarded to someone at the beginning of their career who is under 35 years old. In 2022,

352-512: A spike ferritin-based nanoparticle (SpFN). This vaccine began a Phase I clinical trial in April 2022. Results of this trial were published in May 2024. Other universal vaccines that have entered clinical trial include OVX033 (France), PanCov (France), pEVAC-PS (UK), and VBI-2902 (Canada). Another strategy is to attach vaccine fragments from multiple strains to a nanoparticle scaffold. One theory

396-510: Is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), the virus that causes coronavirus disease 2019 ( COVID‑19 ). Before the COVID‑19 pandemic , an established body of knowledge existed about the structure and function of coronaviruses causing diseases like severe acute respiratory syndrome ( SARS ) and Middle East respiratory syndrome ( MERS ). This knowledge accelerated

440-498: Is that a broader range of strains can be vaccinated against by targeting the receptor-binding domain, rather than the whole spike protein . As of September 2020 , eleven of the vaccine candidates in clinical development use adjuvants to enhance immunogenicity. An immunological adjuvant is a substance formulated with a vaccine to elevate the immune response to an antigen , such as the COVID‑19 virus or influenza virus. Specifically, an adjuvant may be used in formulating

484-653: Is the same as Convidecia's only dose. In August 2021, the developers of Sputnik V proposed, in view of the Delta case surge, that Pfizer test the Ad26 component (termed its 'Light' version) as a booster shot. Inactivated vaccines consist of virus particles that are grown in culture and then killed using a method such as heat or formaldehyde to lose disease-producing capacity while still stimulating an immune response. Inactivated virus vaccines authorized in China include

SECTION 10

#1732765327974

528-459: The Janssen COVID‑19 vaccine , and vaccines with three-dose schedules, Razi Cov Pars and Soberana . However, immunity from the vaccines has been found to wane over time, requiring people to get booster doses of the vaccine to maintain protection against COVID‑19. The COVID‑19 vaccines are widely credited for their role in reducing the spread of COVID‑19 and reducing

572-534: The Oxford–AstraZeneca COVID‑19 vaccine , the Sputnik V COVID‑19 vaccine , Convidecia , and the Janssen COVID‑19 vaccine . Convidecia and Janssen are both one-shot vaccines that offer less complicated logistics and can be stored under ordinary refrigeration for several months. Sputnik V uses Ad26 for its first dose, which is the same as Janssen's only dose, and Ad5 for the second dose, which

616-674: The United Steelworkers announced that the two unions have entered into a strategic alliance to take on the globalization of the culture industry and to address a range of common issues. ACTRA participated in the Faster, Together campaign to increase acceptance of COVID-19 vaccines . ACRA over time evolved into the Association of Canadian Radio and Television Artists, the Canadian Council of Authors and Artists,

660-413: The nasal mucosa , which is a portal for viral entry into the body. These vaccines are designed to stimulate nasal immune factors , such as IgA . In addition to inhibiting the virus, nasal vaccines provide ease of administration because no needles (or needle phobia ) are involved. A variety of intranasal COVID‑19 vaccines are undergoing clinical trials. The first authorised intranasal vaccine

704-631: The Association of Canadian Television and Radio Artists, and, in 1984, the Alliance of Canadian Cinema, Television and Radio Artists. Regional issues led to the creation of the Union of British Columbia Performers , a separate subunit of ACTRA for British Columbia only. Every year, ACTRA branches across the country present the ACTRA Awards , some of which are handed out for performances, while others are given for union activism and contributions to

748-934: The Chinese CoronaVac and the Sinopharm BIBP and WIBP vaccines; there is also the Indian Covaxin , the Russian CoviVac , the Kazakh vaccine QazVac , and the Iranian COVIran Barekat . Vaccines in clinical trials include the Valneva COVID‑;19 vaccine . Subunit vaccines present one or more antigens without introducing whole pathogen particles. The antigens involved are often protein subunits , but they can be any molecule fragment of

792-785: The European Union. Authorized vaccines of this type include the Pfizer–BioNTech and Moderna vaccines. The CVnCoV RNA vaccine from CureVac failed in clinical trials. Severe allergic reactions are rare. In December 2020, 1,893,360 first doses of Pfizer–BioNTech COVID‑19 vaccine administration resulted in 175 cases of severe allergic reactions, of which 21 were anaphylaxis . For 4,041,396 Moderna COVID‑19 vaccine dose administrations in December 2020 and January 2021, only ten cases of anaphylaxis were reported. Lipid nanoparticles (LNPs) were most likely responsible for

836-779: The Prix Gémeaux announced that they would move to presenting ungendered categories for Best Performance, in lieu of separate categories for actors and actresses. This followed a similar announcement by the Canadian Screen Awards earlier in 2022. ACTRA The Alliance of Canadian Cinema, Television and Radio Artists ( ACTRA ) is a Canadian trade union representing performers in English-language media. It has over 30,000 members working in film , television , radio , and all other recorded media. The organization negotiates, safeguards, and promotes

880-561: The United States beginning in fall 2024 should be monovalent JN.1 vaccines. Since January 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. Multiple steps along the entire development path are evaluated, including: There have been several unique challenges with COVID‑19 vaccine development. Public health programs have been described as "[a] race to vaccinate individuals" with

924-514: The adjuvant of choice in some 80% of adjuvanted vaccines. The alum adjuvant initiates diverse molecular and cellular mechanisms to enhance immunogenicity, including the release of proinflammatory cytokines. In June 2024, the US Food and Drug Administration (FDA) advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in

SECTION 20

#1732765327974

968-430: The allergic reactions. These vaccines are examples of non-replicating viral vector vaccines using an adenovirus shell containing DNA that encodes a SARS‑CoV‑2 protein. The viral vector-based vaccines against COVID‑19 are non-replicating, meaning that they do not make new virus particles but rather produce only the antigen that elicits a systemic immune response. Authorized vaccines of this type include

1012-767: The awards ceremony was in 2008. In 2013, the Academy decided to keep the Prix Gémeaux separate from the merged Canadian Screen Awards . The Academy decided on this separation because French-language television does not have strong viewership in English Canada and there is a strong recognition of French-speaking celebrities among Quebecois people. In 2015, many categories were separated or renamed in response to production studios boycotting previous ceremonies. The Academy eliminated Best Soap Opera and replaced Best Drama Series with Best Annual Drama Series for shows that have between 2 and 13 episodes, Best Seasonal Drama Series for 14 to 26 episodes, and Best Daily Drama Show. In 2018

1056-528: The body how to identify and destroy the corresponding pathogen. RNA vaccines often use nucleoside-modified messenger RNA . The delivery of mRNA is achieved by a coformulation of the molecule into lipid nanoparticles , which protect the RNA strands and help their absorption into the cells. RNA vaccines are the first COVID‑19 vaccines to be authorized in the United Kingdom, the United States, and

1100-436: The development of various vaccine platforms in early 2020. The initial focus of SARS-CoV-2 vaccines was on preventing symptomatic, often severe, illness. In 2020, the first COVID‑19 vaccines were developed and made available to the public through emergency authorizations and conditional approvals. Initially, most COVID‑19 vaccines were two-dose vaccines, with the exception single-dose vaccines Convidecia and

1144-501: The doses purchased by high-income countries comprising 14% of the world's population. Despite the extremely rapid development of effective mRNA and viral vector vaccines , worldwide vaccine equity has not been achieved. The development and use of whole inactivated virus (WIV) and protein-based vaccines have also been recommended, especially for use in developing countries . The 2023 Nobel Prize in Physiology or Medicine

1188-527: The elderly, children, pregnant women , and people with weakened immune systems . Several COVID‑19 vaccines, such as the Pfizer–BioNTech and Moderna vaccines, use RNA to stimulate an immune response. When introduced into human tissue, the vaccine contains either self-replicating RNA or messenger RNA (mRNA), which both cause cells to express the SARS-CoV-2 spike protein . This teaches

1232-429: The family Coronaviridae that affect humans have been aimed at severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Vaccines against SARS and MERS have been tested in non-human animals . According to studies published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and public health agencies around

1276-516: The immune system and lessen the severity of COVID‑19 infections. There is experimental evidence that the BCG vaccine for tuberculosis has non-specific effects on the immune system, but there is no evidence that this vaccine is effective against COVID‑19. Most coronavirus vaccines are administered by injection, with further vaccine delivery methods being studied for future coronavirus vaccines. Intranasal vaccines target mucosal immunity in

1320-810: The industry. The ACTRA Fraternal Benefit Society (AFBS), a member of American Fraternal Alliance , is a "not-for-profit, member-owned, federally incorporated insurance company", founded in 1959. In 2010, Marie Charette-Poulin sat on the board of Governors of the ACTRA Fraternal Benefit Society. On 1 June 2019, ACTRA and the Directors Guild of Canada jointly launched HAVEN Helpline for members in Canada, with 24-7 support, out-sourced from Morneau Shepell , with additional financial support from AFBS and Telefilm Canada . COVID-19 vaccine A COVID‑19 vaccine

1364-540: The injection site, fatigue, headache, myalgia (muscle pain), and arthralgia (joint pain), which resolve without medical treatment within a few days. COVID‑19 vaccination is safe for people who are pregnant or are breastfeeding. As of 12 August 2024 , 13.72   billion doses of COVID‑19 vaccines have been administered worldwide, based on official reports from national public health agencies . By December 2020, more than 10 billion vaccine doses had been preordered by countries, with about half of

Prix Gémeaux - Misplaced Pages Continue

1408-451: The jury would meet to choose by consensus two to five people to be nominated. The nominees would be announced in June. After a rules change in 2015, the juries for each category were replaced with six juries whose membership was decided by broadcasters. Before 2015, the process of awarding Prix Gémeaux consisted of a weighted vote; 50% of the weighted vote was from the nomination jury while 50%

1452-516: The pathogen. The authorized vaccines of this type include the peptide vaccine EpiVacCorona , ZF2001 , MVC-COV1901 , Corbevax , the Sanofi–GSK vaccine , and Soberana 02 (a conjugate vaccine ). Bimervax (selvacovatein) was approved for use as a booster vaccine in the European Union in March 2023. The V451 vaccine was in clinical trials that were terminated after it was found that

1496-399: The platforms of vaccine candidates in clinical trials are focused on the coronavirus spike protein (S protein) and its variants as the primary antigen of COVID‑19 infection, since the S protein triggers strong B-cell and T-cell immune responses. However, other coronavirus proteins are also being investigated for vaccine development, like the nucleocapsid , because they also induce

1540-665: The professional rights of its members. It also works to increase work opportunities for its members and lobbies for policy changes at the municipal, provincial, and federal levels. ACTRA's regional chapters present ACTRA Awards to honour the best in Canadian radio and television performances in their local productions. ACTRA is affiliated with the Canadian Labour Congress and the International Federation of Actors . In July 2005, ACTRA and

1584-548: The severity and death caused by COVID‑19. According to a June 2022 study, COVID‑19 vaccines prevented an additional 14.4 to 19.8 million deaths in 185 countries and territories from 8 December 2020 to 8 December 2021. Many countries implemented phased distribution plans that prioritized those at highest risk of complications, such as the elderly, and those at high risk of exposure and transmission, such as healthcare workers. Common side effects of COVID‑19 vaccines include soreness, redness, rash, inflammation at

1628-413: The synthetic vaccines use a 2P mutation to lock the spike protein into its prefusion configuration, stimulating an adaptive immune response to the virus before it attaches to a human cell. Vaccine platforms in development may improve flexibility for antigen manipulation and effectiveness for targeting mechanisms of COVID‑19 infection in susceptible population subgroups, such as healthcare workers,

1672-615: The vaccine may potentially cause incorrect results for subsequent HIV testing. The authorized vaccines of this type include the Novavax COVID‑19 vaccine . Additional types of vaccines that are in clinical trials include multiple DNA plasmid vaccines , at least two lentivirus vector vaccines, a conjugate vaccine , and a vesicular stomatitis virus displaying the SARS‑CoV‑2 spike protein. Scientists investigated whether existing vaccines for unrelated conditions could prime

1716-720: The world at that time. There is no cure or protective vaccine proven to be safe and effective against SARS in humans. There is also no proven vaccine against MERS. When MERS became prevalent, it was believed that existing SARS research might provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection. As of March 2020, there was one (DNA-based) MERS vaccine that completed Phase   I clinical trials in humans, and three others in progress, all being viral-vectored vaccines: two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac) and one MVA -vectored (MVA-MERS-S). Vaccines that use an inactive or weakened virus that has been grown in eggs typically take more than

1760-505: Was Razi Cov Pars in Iran at the end of October 2021. The first viral component of Sputnik V vaccine was authorised in Russia as Sputnik Nasal in April 2022. In September 2022, India and China approved two nasal COVID‑19 vaccines ( iNCOVACC and Convidecia ), which may (as boosters) also reduce transmission (potentially via sterilizing immunity). In December 2022, China approved

1804-586: Was awarded to Katalin Karikó and Drew Weissman for the development of effective mRNA vaccines against COVID-19. Prior to COVID‑19, a vaccine for an infectious disease had never been produced in less than several years – and no vaccine existed for preventing a coronavirus infection in humans. However, vaccines have been produced against several animal diseases caused by coronaviruses, including (as of 2003) infectious bronchitis virus in birds, canine coronavirus , and feline coronavirus . Previous projects to develop vaccines for viruses in

Prix Gémeaux - Misplaced Pages Continue

1848-491: Was previously cleared for Ebola. As multiple COVID‑19 vaccines have been authorized or licensed for use, real-world vaccine effectiveness (RWE) is being assessed using case control and observational studies. A study is investigating the long-lasting protection against SARS-CoV-2 provided by the mRNA vaccines. As of July 2021, at least nine different technology platforms were under research and development to create an effective vaccine against COVID‑19. Most of

1892-542: Was publicly endorsed by NIAID director Anthony Fauci , virologist Jeffery K. Taubenberger , and David M. Morens. In March 2022, the White House released the "National COVID‑19 Preparedness Plan", which recommended accelerating the development of a universal coronavirus vaccine. One attempt at such a vaccine is being developed at the Walter Reed Army Institute of Research . It uses

1936-511: Was weighted from members of the Academy. Each voter would rank the nominees from best to worst. After 2015, the weighted vote was recalculated and the nomination juries were 70% of the weighted total while 20% was decided by Academy members. The remaining 10% was based on the show's ratings and each program was ranked by Numeris . For awards of merit, there are 84 television categories and 15 digital media categories. The Academy also awards Special Awards for various achievements. The Academy appoints

#973026